Vera Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Vera Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Vera Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
  • Vera Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2022 was $1K.
  • Vera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1K, unchanged from 2022.
  • Vera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $1K, unchanged from 2021.
  • Vera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $1K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $1K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $1K +$2K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$1K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.